• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者谷氨酸神经传递减少——一项活体¹³C磁共振波谱研究

Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

作者信息

Lin Alexander P, Shic Frederick, Enriquez Cathleen, Ross Brian D

机构信息

Clinical Spectroscopy Unit, Huntington Medical Research Institutes, 660 S Fair Oaks Avenue, Pasadena, CA 91105, USA.

出版信息

MAGMA. 2003 Feb;16(1):29-42. doi: 10.1007/s10334-003-0004-x.

DOI:10.1007/s10334-003-0004-x
PMID:12695884
Abstract

Cognitive impairment in Alzheimer's disease (AD) is not fully explained. PET indicates reduced cerebral metabolic rate for glucose. Since glutamate neurotransmission (GNT) consumes more than 80% of the ATP generated from metabolism, a pilot study was carried out to determine the neuronal tricarboxylic acid cycle (TCA) based on the hypothesis that reduced GNT could contribute to cognitive impairment in AD. Three AD patients with cognitive impairment (mini-mental state exam: 24 vs 30, P<0.05) and significant reduction in both N-acetyl aspartate (NAA)/Creatine (Cr) ( P<0.009) and NAA/myo-inositol (mI) ratio ( P<0.01), and three age-matched controls each received 0.014-0.016 g/kg/min 99%1-13C glucose IV. Quantitative (1)H and proton-decoupled (13)C MR brain spectra were acquired from combined posterior-parietal white matter and posterior-cingulate gray matter every 5 min for 140 min.(13)C magnetic resonance spectroscopy (MRS) measures of glucose oxidation and neuronal TCA rate, including prolonged time to (13)C enrichment of glutamate (Glu2) ( P<0.004) and bicarbonate (HCO(3)) ( P<0.03) as well as reduced relative enrichment of Glu(2)/Glu(4) between 60 and 100 min ( P<0.04), were significantly different in AD patients vs. controls. (13)C measures of GNT, glutamine (Gln)(2)/Glu(2) ( P<0.02) and rates of glutamate enrichment (Glu(2)/glucose: 0.34 vs 0.86, P=ns and Glu(4)/glucose 0.26 vs 0.83, P=ns), were also reduced.(13)C MRS measures of neuronal TCA cycle, glucose oxidation and GNT were significantly correlated with measures of neuronal integrity: NAA/Cr, [NAA] and mI/NAA as determined by (1)H MRS ( R(2)=0.73-0.95; P<0.05-0.01), suggesting that impairment of GNT may be a contributing factor in the cognitive impairment characteristic of AD.

摘要

阿尔茨海默病(AD)中的认知障碍尚未得到充分解释。正电子发射断层扫描(PET)显示大脑葡萄糖代谢率降低。由于谷氨酸神经传递(GNT)消耗了代谢产生的80%以上的三磷酸腺苷(ATP),因此进行了一项初步研究,以基于GNT降低可能导致AD认知障碍的假设来确定神经元三羧酸循环(TCA)。三名患有认知障碍的AD患者(简易精神状态检查:24分对30分,P<0.05),N-乙酰天门冬氨酸(NAA)/肌酸(Cr)(P<0.009)和NAA/肌醇(mI)比值均显著降低(P<0.01),以及三名年龄匹配的对照组,每组静脉注射0.014 - 0.016 g/kg/min的99% 1-13C葡萄糖。每5分钟从顶叶后白质和扣带回后灰质联合处采集定量(1)H和质子去耦(13)C磁共振脑谱,共采集140分钟。(13)C磁共振波谱(MRS)对葡萄糖氧化和神经元TCA速率的测量,包括谷氨酸(Glu2)(P<0.004)和碳酸氢盐(HCO₃)(P<0.03)的(13)C富集时间延长,以及60至100分钟之间Glu(2)/Glu(4)的相对富集降低(P<0.04),在AD患者与对照组之间有显著差异。(13)C对GNT、谷氨酰胺(Gln)(2)/Glu(2)(P<0.02)以及谷氨酸富集速率(Glu(2)/葡萄糖:0.34对0.86,P=无显著差异;Glu(4)/葡萄糖0.26对0.83,P=无显著差异)的测量也降低。(13)C MRS对神经元TCA循环、葡萄糖氧化和GNT的测量与神经元完整性的测量显著相关:由(1)H MRS测定的NAA/Cr、[NAA]和mI/NAA(R² = 0.73 - 0.95;P<0.05 - 0.01),表明GNT受损可能是AD特征性认知障碍的一个促成因素。

相似文献

1
Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.阿尔茨海默病患者谷氨酸神经传递减少——一项活体¹³C磁共振波谱研究
MAGMA. 2003 Feb;16(1):29-42. doi: 10.1007/s10334-003-0004-x.
2
¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.¹H-和¹³C-NMR 光谱分析 Thy-1-APPSL 小鼠脑提取物表明阿尔茨海默病的代谢变化。
J Neural Transm (Vienna). 2015 Apr;122(4):541-50. doi: 10.1007/s00702-015-1387-3. Epub 2015 Mar 6.
3
Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.阿尔茨海默病中的磁共振波谱:系统评价与荟萃分析
J Alzheimers Dis. 2015;46(4):1049-70. doi: 10.3233/JAD-143225.
4
Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.采用0.5T的氢质子磁共振波谱(¹H-MRS)在体检测发现阿尔茨海默病患者体内谷氨酸+谷氨酰胺含量降低。
Neurology. 2001 Mar 27;56(6):737-42. doi: 10.1212/wnl.56.6.737.
5
Clinical experience with 13C MRS in vivo.13C磁共振波谱成像的体内临床经验。
NMR Biomed. 2003 Oct-Nov;16(6-7):358-69. doi: 10.1002/nbm.852.
6
Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.通过质子磁共振波谱检测早期阿尔茨海默病神经病理学
J Neurosci. 2014 Dec 3;34(49):16247-55. doi: 10.1523/JNEUROSCI.2027-14.2014.
7
Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.采用3特斯拉磁共振波谱检测轻度认知障碍和阿尔茨海默病患者海马体和后扣带回区域的代谢变化。
Acta Radiol. 2009 Apr;50(3):312-9. doi: 10.1080/02841850802709219.
8
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病中的海马体代谢异常。
Neurosci Lett. 2005;384(1-2):23-8. doi: 10.1016/j.neulet.2005.04.035.
9
The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.临床阿尔茨海默病和血管性痴呆患者认知障碍与体内代谢物比率的关系:一项质子磁共振波谱研究
Neuroradiology. 2003 Aug;45(8):507-12. doi: 10.1007/s00234-003-1040-y. Epub 2003 Jul 22.
10
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.阿尔茨海默病颞叶的体内质子磁共振波谱分析
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22. doi: 10.1016/j.pnpbp.2004.08.013.

引用本文的文献

1
Metabolic Dysregulation in Parkinson's Disease: Non-Oxidative Phosphorylation and Its Role in Brain Energy Metabolism.帕金森病中的代谢失调:非氧化磷酸化及其在脑能量代谢中的作用
Aging Dis. 2025 Jun 22;16(5):2721-2738. doi: 10.14336/AD.2025.0619.
2
Reproducibility of the Determination of C-Labeling of Glutamate and Glutamine in the Human Brain Using selPOCE-MRS at 7 T Upon [U-C]-Labeled Glucose Infusion.在7T磁场下,静脉输注[U-C]标记葡萄糖后,使用selPOCE-MRS测定人脑中谷氨酸和谷氨酰胺C标记的可重复性。
NMR Biomed. 2025 May;38(5):e70026. doi: 10.1002/nbm.70026.
3
Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer's Disease.

本文引用的文献

1
Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.海马体体积作为阿尔茨海默病神经病理学指标:修女研究的发现。
Neurology. 2002 May 28;58(10):1476-82. doi: 10.1212/wnl.58.10.1476.
2
Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
Psychol Med. 2002 Apr;32(3):483-91. doi: 10.1017/s003329170200524x.
3
Alzheimer disease.阿尔茨海默病
JAMA. 2002 May 8;287(18):2335-8. doi: 10.1001/jama.287.18.2335.
血清异亮氨酸与轻度认知障碍及阿尔茨海默病的关联。
Ann Geriatr Med Res. 2024 Sep;28(3):273-283. doi: 10.4235/agmr.23.0216. Epub 2024 Apr 23.
4
Estimating the synaptic density deficit in Alzheimer's disease using multi-contrast CEST imaging.利用多对比度 CEST 成像估计阿尔茨海默病中的突触密度缺失。
PLoS One. 2024 Mar 14;19(3):e0299961. doi: 10.1371/journal.pone.0299961. eCollection 2024.
5
The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer's Disease Mouse Model.特异性切割 tau 12A12mAb 通过调节阿尔茨海默病小鼠模型中的内吞和生物能量途径发挥抗淀粉样蛋白形成作用。
Int J Mol Sci. 2023 Jun 2;24(11):9683. doi: 10.3390/ijms24119683.
6
Mapping of glutamate metabolism using 1H FID-MRSI after oral administration of [1-13C]Glc at 9.4 T.在 9.4T 下口服 [1-13C]Glc 后使用 1H FID-MRSI 进行谷氨酸代谢谱成像
Neuroimage. 2023 Apr 15;270:119940. doi: 10.1016/j.neuroimage.2023.119940. Epub 2023 Feb 12.
7
Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases.代谢组学作为开发神经退行性疾病新治疗策略的关键工具。
Metabolites. 2022 Sep 14;12(9):864. doi: 10.3390/metabo12090864.
8
Sphingolipids and DHA Improve Cognitive Deficits in Aged Beagle Dogs.鞘脂类和二十二碳六烯酸可改善老年比格犬的认知缺陷。
Front Vet Sci. 2022 Jul 13;9:646451. doi: 10.3389/fvets.2022.646451. eCollection 2022.
9
Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer's Disease.敌友难辨?解析谷氨酸在衰老及阿尔茨海默病中的作用
Front Aging. 2022 Jun 16;3:929474. doi: 10.3389/fragi.2022.929474. eCollection 2022.
10
Is the Brain Undernourished in Alzheimer's Disease?阿尔茨海默病患者的大脑是否营养不良?
Nutrients. 2022 Apr 29;14(9):1872. doi: 10.3390/nu14091872.
4
The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)所揭示的阿尔茨海默病情景记忆障碍的神经基础:与病情恶化程度的关系
Brain. 2002 May;125(Pt 5):1116-24. doi: 10.1093/brain/awf097.
5
Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.3特斯拉下对阿尔茨海默病患者谷氨酸/谷氨酰胺进行的质子磁共振波谱研究。
Neuroreport. 2002 Jan 21;13(1):183-6. doi: 10.1097/00001756-200201210-00041.
6
Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism.13C核磁共振波谱揭示人类星形胶质细胞对脑能量代谢的贡献:阐明神经递质谷氨酸补充的主要途径并测量星形胶质细胞的氧化代谢
J Neurosci. 2002 Mar 1;22(5):1523-31. doi: 10.1523/JNEUROSCI.22-05-01523.2002.
7
Tricarboxylic acid cycle of glia in the in vivo human brain.体内人类大脑中神经胶质细胞的三羧酸循环
NMR Biomed. 2002 Feb;15(1):1-5. doi: 10.1002/nbm.725.
8
Genotype and phenotype in Alzheimer's disease.阿尔茨海默病中的基因型与表型
Br J Psychiatry. 2002 Feb;180:131-4. doi: 10.1192/bjp.180.2.131.
9
Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh.阿尔茨海默病与唐氏综合征:淀粉样前体蛋白、营养因子及乙酰胆碱的作用
Trends Neurosci. 2002 Feb;25(2):79-84. doi: 10.1016/s0166-2236(02)02037-4.
10
Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease.阿尔茨海默病中谷氨酰胺合成酶细胞分布的变化。
J Neurosci Res. 2001 Dec 1;66(5):972-80. doi: 10.1002/jnr.10057.